The appearance of abdominal pain has no fixed pattern of appearance in the COVID-19 clinical course. Abdominal pain may be the acute presenting symptom or one of numerous symptoms in a COVID-19 patient with intensity ranging from mild to severe.   A complication reported is gut perforation due to ischemia. Patients may present with gut perforation as the first sign of COVID-19 infection.  Upper GI bleed (due to esophageal mucosal damage as observed on endoscopy) has been reported among 4% of patients with other GI symptoms such as abdominal pain related to novel coronavirus infection. It is not known whether bleeding is a complication of other entities or a separate phenomenon in COVID-19 infection but has been mentioned together with abdominal pain. The esophagus, stomach, duodenum and stool have been tested positive for viral RNA.   Prognosis: In a meta-analysis by Mao R. et al. the odds of severe disease among patients with abdominal pain as one of the gastrointestinal symptoms were 7.10.
What is abdominal pain associated with COVID-19?
<s>[INST] Answer the question truthfully, you are a medical professional. This is the question: What is abdominal pain associated with COVID-19? [/INST] \n The appearance of abdominal pain has no fixed pattern of appearance in the COVID-19 clinical course. Abdominal pain may be the acute presenting symptom or one of numerous symptoms in a COVID-19 patient with intensity ranging from mild to severe.   A complication reported is gut perforation due to ischemia. Patients may present with gut perforation as the first sign of COVID-19 infection.  Upper GI bleed (due to esophageal mucosal damage as observed on endoscopy) has been reported among 4% of patients with other GI symptoms such as abdominal pain related to novel coronavirus infection. It is not known whether bleeding is a complication of other entities or a separate phenomenon in COVID-19 infection but has been mentioned together with abdominal pain. The esophagus, stomach, duodenum and stool have been tested positive for viral RNA.   Prognosis: In a meta-analysis by Mao R. et al. the odds of severe disease among patients with abdominal pain as one of the gastrointestinal symptoms were 7.10.</s>